Pharmacy Times
JULY 9, 2024
In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.
Drug Topics
JULY 8, 2024
Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 11, 2024
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives a clearer sense of just how many cancer cases and deaths may be driven by drinking. Researchers from the American Cancer Society and International Agency for Research on Cancer estimate 40% of all cancer cases in the United States in people 30 and up were due to “potentially modifiable risk factors,” including cigarette smoking, physical inactivity, consumption of processed meat, vi
Fierce Healthcare
JULY 8, 2024
U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year. | U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 11, 2024
In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Drug Topics
JULY 10, 2024
A former sergeant first class in the US Army discussed PTSD in an exclusive interview with Drug Topics.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JULY 9, 2024
OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup, Thrive AI Health, that aims to build an AI health coach to promote healthier lifestyles. | OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup that aims to build an AI health coach to promote healthier lifestyles.
Pharmacy Times
JULY 12, 2024
Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.
Drug Topics
JULY 12, 2024
Global coverage for diphtheria, tetanus, and pertussis has reached its lowest point in 15 years.
STAT
JULY 11, 2024
As Covid-19 swept across the United States, schools were among the most highly affected public spaces. To prepare for a potential H5N1 avian influenza jump to humans, schools need to be preparing for the scenario now before a sustained transmission event occurs. The response to Covid-19, which first appeared in the U.S. in early 2020, has been scrutinized by numerous case studies, after-action reports , and Congressional fact-finding hearings.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JULY 11, 2024
The Centers for Medicare & Medicaid Services' (CMS') proposed calendar year 2025 physician fee schedule rule, out Wednesday, proposed an assortment of new payments and coverage for digital heal | CMS' proposed changes to digital health payment for physicians includes new codes for mental health-related digital therapeutics, an assortment of telehealth extensions and more flexibilities for opioid treatment programs to use audio and video telehealth services.
Pharmacy Times
JULY 11, 2024
Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Drug Topics
JULY 8, 2024
When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.
STAT
JULY 11, 2024
WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of people seriously ill from cancer, diabetes, or heart disease: a Jimmy Dean frozen sausage breakfast sandwich, biscuits and gravy, a cheeseburger. These are among the offerings sold by an Idaho-based company, Homestyle Direct, which is paid millions of dollars each year by taxpayer-funded state Medicaid programs to deliver what the company calls medically tailore
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
JULY 11, 2024
Even as pharma companies have yet to feel the full effects of the Inflation Reduction Act, Senate lawmakers have turned their attention to another facet of drug pricing with a bill meant to cr | The bill looks to limit the number of patents that companies can assert in litigation on individual products. It's intended to crack down on "patent thickets," which can delay and thwart generic competition.
Pharmacy Times
JULY 12, 2024
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
Drug Topics
JULY 9, 2024
Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.
STAT
JULY 9, 2024
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men and 10 women who came to a sprawling medical campus in downtown Buffalo, N.Y., to volunteer for what a news report had billed as “the world’s biggest science project.
Fierce Healthcare
JULY 8, 2024
Healthcare industry groups are urging the federal government to streamline and loosen a recent proposed rule outlining cybersecurity incident reporting requirements for entities considered to be cr | Hospitals, practices, information management executives and even insurers criticized a proposed rule for its overlap with other federal reporting requirements and limited oversight of smaller third-parties, among other concerns.
Pharmacy Times
JULY 11, 2024
Prevalence of dry eye is increasing drastically, especially in younger individuals, because of the current lifestyle and increased technology use.
Fierce Pharma
JULY 8, 2024
Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? | Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? While a head-to-head trial pitting the two treatments remains ongoing, new evidence shows that Lilly’s tirzepatide may be the superior weight loss product.
STAT
JULY 8, 2024
Come quickly, the Columbus Police sergeant urged, patients are in danger. The psychiatric hospital on the city’s east side may need to be shut down, he warned Ohio regulators. The officer, a 27-year veteran of the department, knew that sending the February letter was an unusual thing to do, but meetings with hospital leaders had gone nowhere, and he was at his wit’s end.
Fierce Healthcare
JULY 12, 2024
ONC's HTI-2 proposed rule 'big step forward' for interoperability, health IT experts say, but EHR vendors concerned about timelines hlandi Fri, 07/12/2024 - 14:43
Pharmacy Times
JULY 10, 2024
Investigation confirms massive middlemen employ tactics like steering, inflated costs, low reimbursements, harmful contractual terms, etc, that hurt patients and independent pharmacies.
pharmaphorum
JULY 11, 2024
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the prices of medicines in the US.
STAT
JULY 11, 2024
WASHINGTON — When Elmo asked “How is everybody doing?” back in January, he was not expecting the onslaught of stress, despair, and anxiety that hit his replies. “I’m just looking for somebody to talk to and show me some love if you know what I mean,” famous singer T-Pain wrote back to the red Muppet.
Fierce Healthcare
JULY 11, 2024
A recent lawsuit has pushed back against an industry-opposed Centers for Medicare & Medicaid Services (CMS) final rule on broker compensation in Medicare Advantage (MA) plans. | A district court in Texas is halting a federal rule that changes broker compensation and overhauls marketing to seniors.
Pharmacy Times
JULY 11, 2024
Previous studies have shown that individuals living with HIV are at higher risk for heart disease than individuals without HIV
Fierce Pharma
JULY 12, 2024
Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.
STAT
JULY 8, 2024
Imagine this post-9/11 scenario: A New York City fire company is forced to shut down and lay off its firefighters because some Americans believe a bizarre conspiracy theory that this fire company brought down the World Trade Center towers. A Covid-19 version of this freakish tale is happening today. Instead of a fire company, the conspiracy gang is targeting an important, successful, decades-old nonprofit organization that researches viral epidemics and tries to predict and forestall future
Fierce Healthcare
JULY 10, 2024
Just one day after issuing a report blasting pharmacy benefit managers for their business practices and focus on consolidation and vertical integration, the Federal Trade Commission (FTC) is report | The FTC is planning legal action against pharmacy benefit managers for rebate tactics that may hinder consumers and independent pharmacies.
Drug Topics
JULY 8, 2024
Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.
pharmaphorum
JULY 10, 2024
Learn how to successfully transition pilots into production with GenAI in the pharmaceutical industry. Discover strategies to create, scale, and achieve success with this innovative technology.
STAT
JULY 8, 2024
A study published Monday provides new evidence that the H5N1 virus currently causing an outbreak of bird flu in U.S. dairy cattle may be adapted to better infecting humans than other circulating strains of the virus, a result that is already courting controversy among the world’s leading flu researchers. Across the globe, different influenza viruses are constantly circulating in many different kinds of animals.
Expert insights. Personalized for you.
149 
Let's personalize your content